Stoke Therapeutics, Inc.

STOKCIK 0001623526 · Every Form 4 filed by insiders at this issuer.

Filings

9

Latest Mar 19, 2024

Unique insiders

6

Showing

9 of 9

Page 1

Top insiders

Most active reporters at Stoke Therapeutics, Inc.

NameRolesFilings
Ticho Barry
Officer
4
Allan Jonathan
Officer
1
Kaye Edward M. MD
OfficerDirector
1
Nash Huw M.
Officer
1
TZIANABOS ARTHUR
Director
1
Tulipano Stephen J
Officer
1

All filings

9 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 19, 2024
Allan Jonathan
GENERAL COUNSEL & CORP SEC
S2,349$6.0986$14,326
Mar 19, 2024
Kaye Edward M. MD
CEO · Director
S11,150$6.0986$67,999
Mar 19, 2024
Nash Huw M.
COO & CBO
S4,116$6.0986$25,102
Mar 19, 2024
Ticho Barry
CHIEF MEDICAL OFFICER
S4,116$6.0986$25,102
Mar 19, 2024
Tulipano Stephen J
CFO
S4,116$6.0986$25,102
Mar 5, 2024
Ticho Barry
CHIEF MEDICAL OFFICER
S10,000$7.7469$77,469
Feb 15, 2024
TZIANABOS ARTHUR
Director
M31,739$2.19$69,508
Feb 5, 2024
Ticho Barry
CHIEF MEDICAL OFFICER
S10,000$4.7991$47,991
Jan 4, 2024
Ticho Barry
Chief Medical Officer
S10,000$5.7352$57,352

Showing 19 of 9

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.